Retractable Technologies (RVP) Non Operating Investment Income (2022 - 2026)
Retractable Technologies' (RVP) quarterly Non Operating Investment Income came in at -$179147.0 in Q2 2026, down 111.52% on a YoY basis from $1.6 million in Q2 2025, and down 193.22% quarter-over-quarter from $192172.0 in Q1 2026.
Powered by 
Analysis
Retractable Technologies (RVP) Non Operating Investment Income (2022 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Non Operating Investment Income for 5 consecutive years, with -$179147.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Investment Income fell 111.52% year-over-year to -$179147.0; the trailing twelve-month figure through Jun 2026 stood at $594092.0 (down 88.7% YoY), and the FY2025 full-year result was -$5.0 million, down 146.59% from the prior year.
- Non Operating Investment Income retreated to -$179147.0 in Q2 2026 per RVP's latest filing, from $192172.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $9.4 million in Q4 2024 and bottomed at -$7.2 million in Q1 2025.
- Historically, Non Operating Investment Income has averaged -$131376.1 across 5 years, with a median of $485503.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Non Operating Investment Income plunged 962.81% in 2023, then soared 1107.87% in 2024.
- Over 5 years, Non Operating Investment Income stood at $3.5 million in 2022, then slumped by 77.94% to $778834.0 in 2023, then jumped by 1107.87% to $9.4 million in 2024, then slumped by 119.34% to -$1.8 million in 2025, then soared by 90.15% to -$179147.0 in 2026.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered -$179147.0, $192172.0, and -$1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | - |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | - |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | - |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | - |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -179,147.00 |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -179,147.00 |
| Mar 31, 2026 | 192,172.00 |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | -7.16 Mn |
| Dec 31, 2024 | 9.41 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | -1.78 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 778,834.00 |
| Sep 30, 2023 | -6.54 Mn |
| Jun 30, 2023 | -6.25 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 3.53 Mn |
| Sep 30, 2022 | -615,215.00 |
| Jun 30, 2022 | -3.90 Mn |
| Mar 31, 2022 | 3.33 Mn |